Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Keywords » - entrée « Respiratory Distress Syndrome (etiology) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Respiratory Distress Syndrome (epidemiology) < Respiratory Distress Syndrome (etiology) < Respiratory Distress Syndrome (immunology)  Facettes :

List of bibliographic references indexed by Respiratory Distress Syndrome (etiology)

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000026 (2021) M. Bovet [Allemagne] ; D. Wadsack [Allemagne] ; F. Kosely [Allemagne] ; W. Zink [Allemagne] ; R. Zahn [Allemagne][Fatal course of COVID-19 despite IL-6 receptor blockade in cytokine storm : Perimyocarditis and coagulopathy after administration of tocilizumab].
000473 (2021) Jihad G. Youssef [États-Unis] ; Faisal Zahiruddin [États-Unis] ; George Youssef [États-Unis] ; Sriram Padmanabhan [États-Unis] ; Joe Ensor [États-Unis] ; Sai Ravi Pingali [États-Unis] ; Youli Zu [États-Unis] ; Sandeep Sahay [États-Unis] ; Swaminathan P. Iyer [États-Unis]G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?
000752 (2021) Simone Sukhdeo [États-Unis] ; Emily Negroponte [États-Unis] ; Hariprem Rajasekhar [États-Unis] ; Sunanda Gaur [États-Unis] ; Daniel B. Horton [États-Unis] ; Amisha Malhotra [États-Unis] ; L Nandini Moorthy [États-Unis]Acute respiratory distress syndrome and COVID-19 in a child with systemic lupus erythematosus.
000980 (2020) Brian Lipworth [Royaume-Uni] ; Rory Chan [Royaume-Uni] ; Samuel Lipworth [Royaume-Uni] ; Chris Ruiwen Kuo [Royaume-Uni]Weathering the Cytokine Storm in Susceptible Patients with Severe SARS-CoV-2 Infection.
000992 (2020) Imen Ben Saida [Tunisie] ; Emna Ennouri [Tunisie] ; Rayane Nachi [Tunisie] ; Khaoula Meddeb [Tunisie] ; Jihene Mahmoud [Tunisie] ; Nesrine Thabet [Tunisie] ; Salma Jerbi [Tunisie] ; Mohamed Boussarsar [Tunisie]Very severe COVID-19 in the critically ill in Tunisia.
000B64 (2020) Serena Colafrancesco [Italie] ; Rossana Scrivo [Italie] ; Cristiana Barbati [Italie] ; Fabrizio Conti [Italie] ; Roberta Priori [Italie]Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients.
001256 (2020) Hiroyuki Fujii [Japon] ; Taisuke Tsuji [Japon] ; Tatsuya Yuba [Japon] ; Shunya Tanaka [Japon] ; Yoshifumi Suga [Japon] ; Aosa Matsuyama [Japon] ; Ayaka Omura [Japon] ; Shinsuke Shiotsu [Japon] ; Chieko Takumi [Japon] ; Seiko Ono [Japon] ; Masahito Horiguchi [Japon] ; Noriya Hiraoka [Japon]High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review : High levels of anti-SSA/Ro antibodies in COVID-19.
001466 (2020) Rosanna Massabeti [Italie] ; Maria Stella Cipriani [Italie] ; Ivana Valenti [Italie]Covid-19: A systemic disease treated with a wide-ranging approach: A case report.
001666 (2020) Caio P. Gomes [Brésil] ; Danilo E. Fernandes [Brésil] ; Fernanda Casimiro [Brésil] ; Gustavo F. Da Mata [Brésil] ; Michelle T. Passos [Brésil] ; Patricia Varela [Brésil] ; Gianna Mastroianni-Kirsztajn [Brésil] ; João Bosco Pesquero [Brésil]Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics.
001866 (2020) Mirko Scarsi [Italie] ; Silvia Piantoni [Italie] ; Enrico Colombo [Italie] ; Paolo Air [Italie] ; Donata Richini [Italie] ; Marco Miclini [Italie] ; Valeria Bertasi [Italie] ; Marta Bianchi [Italie] ; Damiano Bottone [Italie] ; Patrizia Civelli [Italie] ; Maria-Sofia Cotelli [Italie] ; Ezio Damiolini [Italie] ; Gloria Galbassini [Italie] ; Diego Gatta [Italie] ; Maria-Laura Ghirardelli [Italie] ; Roberto Magri [Italie] ; Paola Malamani [Italie] ; Monia Mendeni [Italie] ; Stefano Molinari [Italie] ; Andrea Morotti [Italie] ; Luisa Salada [Italie] ; Marinella Turla [Italie] ; Angiola Vender [Italie] ; Angela Tincani [Italie] ; Antonio Brucato [Italie] ; Franco Franceschini [Italie] ; Roberto Furloni [Italie] ; Laura Andreoli [Italie]Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome.
001904 (2020) S. Prajapati [Inde] ; M. Sharma ; A. Kumar ; P. Gupta ; G V Narasimha KumarAn update on novel COVID-19 pandemic: a battle between humans and virus.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Respiratory Distress Syndrome (etiology)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Respiratory Distress Syndrome (etiology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Respiratory Distress Syndrome (etiology)
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021